Cancer therapy cures two Australian patients of HIV

Image
IANS Sydney
Last Updated : Jul 21 2014 | 4:20 PM IST

In a piece of good news after the sad announcement a few days ago about HIV virus rebounding in the "Mississippi Baby", scientists have uncovered two new cases of HIV patients in whom the virus has become undetectable.

The two Australian men became apparently HIV-free after receiving stem cells to treat cancer, the scientific journal Nature reported.

"They are still on anti-retroviral therapy (ART) 'as a precaution' but those drugs alone could not be responsible for bringing the virus to such low levels," said David Cooper, director of the Kirby Institute at University of New South Wales in Sydney.

Cooper and his team scanned the archives of St Vincent's hospital in Sydney - one of the largest bone-marrow centres in Australia - and found these two patients.

The first patient had received a bone-marrow transplant for non-Hodgkin's lymphoma in 2011.

The other had been treated for leukemia in 2012.

Because of the risk of relapse, Cooper's team will not claim that their patients are completely cured.

According to Cooper, the results show that "there is something about bone-marrow transplantation in people with HIV that has an anti-HIV reservoir effect, such that the reservoirs go down to very low levels".

If we can understand what is that and how that happens, it will really accelerate the field of cure search, Cooper added.

At the moment, there is only one person in the world who is still considered cured of HIV - Timothy Ray Brown.

This "Berlin patient" received a bone-marrow transplant and has had no signs of the virus in his blood for six years without ART.

Stem-cell transplant in itself cannot be used as a routine HIV treatment because of the high mortality (10 percent) associated with the procedure, the Nature report added.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 21 2014 | 4:12 PM IST

Next Story